GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » EPS (Diluted)

AP Biosciences (ROCO:6945) EPS (Diluted) : NT$-5.24 (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences EPS (Diluted)?

AP Biosciences's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was NT$-3.42. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-5.24.

AP Biosciences's EPS (Basic) for the six months ended in Dec. 2023 was NT$-3.42. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-5.24.

AP Biosciences's EPS without NRI for the six months ended in Dec. 2023 was NT$-3.42. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-5.24.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


AP Biosciences EPS (Diluted) Historical Data

The historical data trend for AP Biosciences's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences EPS (Diluted) Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
0.01 -3.89 -5.48 -5.24

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EPS (Diluted) Get a 7-Day Free Trial - -3.33 -2.23 -1.82 -3.42

Competitive Comparison of AP Biosciences's EPS (Diluted)

For the Biotechnology subindustry, AP Biosciences's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AP Biosciences's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AP Biosciences's PE Ratio distribution charts can be found below:

* The bar in red indicates where AP Biosciences's PE Ratio falls into.



AP Biosciences EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

AP Biosciences's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-339.295-0)/64.748
=-5.24

AP Biosciences's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-221.214-0)/64.748
=-3.42

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-5.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AP Biosciences  (ROCO:6945) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


AP Biosciences EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of AP Biosciences's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


AP Biosciences (ROCO:6945) Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences (ROCO:6945) Headlines

No Headlines